文献速递介入腹部DSACTMR

肝细胞癌患者影像学完全缓解后局部复发:经动脉化疗栓塞与经动脉放射栓塞的比较

Local recurrence following a complete radiologic response in hepatocellular carcinoma patients: comparison of transarterial chemoembolisation and transarterial radioembolisation.
PubMed 文献 · Clin Radiol · 2024-01-29

单中心回顾性研究纳入110例影像学完全缓解的肝细胞癌患者(TACE 60例、TARE 50例),TACE组局部复发率51.7%显著高于TARE组18%,局部至进展时间显著更短(HR 7.2),多因素分析示治疗方式与局部复发相关;作者认为TARE后复发可能更少。

要点

  • 影像学完全缓解后,TACE组局部复发31/60(51.7%),TARE组9/50(18%)。
  • TACE组局部复发时间中位8.3个月,TARE组中位17.9个月。
  • 局部至进展多因素分析:TACE较TARE的HR为7.2(95%CI 3.64-14.24)。

核心结论

  • 在选择性治疗并达到影像学完全缓解的肝细胞癌患者中,接受TARE者发生局部或总体复发的可能性似乎低于接受TACE者。

研究设计与样本

  • 单中心回顾性研究,纳入110例(TACE 60例、TARE 50例)影像学完全缓解的肝细胞癌患者,排除既往治疗、多灶病变、非选择性TARE或TACE及未达影像学完全缓解者。

诊断标准与关键数值

  • 影像学完全缓解定义为影像学上达到完全缓解(CR)。
  • 局部复发:TACE组31/60(51.7%)vs TARE组9/50(18%),p<0.001。
  • 局部复发时间:TACE组中位8.3个月(IQR 12)vs TARE组中位17.9个月(IQR 23.5),p=0.001。
  • 局部至进展多因素Cox分析:TACE较TARE的HR 7.2(95%CI 3.64-14.24),p<0.001;治疗方式HR 0.05(95%CI 0.005-0.5),p=0.01。
  • 总体至进展:TACE组较TARE组HR 2.13(95%CI 1.28-3.53),p=0.004。

临床应用与阅片要点

  • TARE组患者年龄更大(66.4±9.4岁 vs TACE组61.2±5.6岁,p<0.001),肿瘤更大(4.4±2.2 cm vs 3±1.4 cm,p=0.002)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate and compare the rates of local recurrence in hepatocellular carcinoma (HCC) patients who undergo selective transarterial radioembolisation (TARE) or transarterial chemoembolisation (TACE) and achieve a complete response (CR) radiologically.

MATERIALS AND METHODS: All patients undergoing treatment with TARE or TACE at a single academic institution were reviewed retrospectively. Those who had been treated previously, presented with multifocal disease, had non-selective TARE or TACE, or did not achieve a complete response (CR) radiologically were excluded.

RESULTS: In total 110 patients were included (TACE n=60 [54.5%]; TARE n=50 [45.5%]). TARE patients were older (66.4 ± 9.4 versus 61.2 ± 5.6 years, p<0.001) and had larger tumours (4.4 ± 2.2 versus 3 ± 1.4 cm, p=0.002). TACE patients were significantly more likely to suffer a local recurrence (31/60, 51.7% versus 9/50, 18%, p<0.001) and had a significantly shorter time to recurrence (median 8.3 {interquartile range [IQR]}: 12 versus median 17.9 [IQR: 23.5] months, p=0.001). A local time to progression (TTP) Kaplan-Meier curve demonstrated TACE patients had a significantly shorter local TTP (hazard ratio [HR]: 7.2; 95% confidence interval [CI]: 3.64-14.24; p<0.001) and treatment modality (TACE or TARE; HR: 0.05; 95% CI: 0.005-0.5; p=0.01) was found to be associated with local recurrences on multivariate Cox proportional HR analysis. When overall TTP was evaluated, again TACE patients were found to have a significantly shorter TTP (HR: 2.13 [1.28-3.53], p=0.004).

CONCLUSION: In HCC patients undergoing selective treatment who achieve a CR radiologically, those treated with TARE may be less likely to suffer recurrence, either local or general, than those treated with TACE.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Young S, Sanghvi T, Ragulojan R, et al. Local recurrence following a complete radiologic response in hepatocellular carcinoma patients: comparison of transarterial chemoembolisation and transarterial radioembolisation. Clin Radiol. 2024. PMID: 38341344. doi:10.1016/j.crad.2024.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。